Result highlights include: Revenue up 27% or $856K to $4.039M Expenses reduced by 12% or $0.69M to ($5.2M) EBITDA up 58% or $1.5M to ($1M) Innovation investments (R&D) increase 84% to $1.468M Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release...
Global Health is excited to present our Annual Report, showcasing our achievements in the past year. The highlights include: 20% increase in Customer Revenue to $7.81 million 11% growth in Annual Recurring Revenue reaching $5.73 million 47% rise in Gross Margin, totaling $4.12 million. In addition, we...
Read the Global Health Limited Half Year Update here: FY21 Half Year Business Update To read more on the ASX click here: ASX Market Announcements - GLH...
Read the Half Yearly Report and Accounts here: 2020-02 Half Yearly Report and Accounts...
Read the Half Year Results Announcement: 2020-02 Half Year Results Announcement...
Read the June 2019 Annual Report to Shareholders here: June 2019 Annual Report to Shareholders...
Please view the Annual Report via this link: June 2019 Preliminary Financial Report here...
Please view the Preliminary Financial Report CEO Commentary via this link: Global Health Preliminary Financial Report CEO Commentary here...